Matches in DBpedia 2014 for { <http://dbpedia.org/resource/Linsitinib> ?p ?o. }
Showing items 1 to 26 of
26
with 100 items per page.
- Linsitinib abstract "Linsitinib is an experimental drug candidate for the treatment of various types of cancer. It is an inhibitor of the insulin receptor and of the insulin-like growth factor 1 receptor (IGF-1R). This prevents tumor cell proliferation and induces tumor cell apoptosis.Linsitinib was discovered by OSI Pharmaceuticals and is currently in Phase III clinical trials for adrenocortical carcinoma and Phase II clinical trials for lung and ovarian cancers.".
- Linsitinib iupacName "3-[8-Amino-1-(2-phenyl-7-quinolyl)imidazo[1,5-a]pyrazin-3-yl]-1-methyl-cyclobutanol".
- Linsitinib thumbnail Linsitinib.svg?width=300.
- Linsitinib wikiPageID "37339814".
- Linsitinib wikiPageRevisionID "600987554".
- Linsitinib hasPhotoCollection Linsitinib.
- Linsitinib imagefile "Linsitinib.svg".
- Linsitinib imagesize "180".
- Linsitinib iupacname "3".
- Linsitinib othernames "OSI-906".
- Linsitinib subject Category:Experimental_cancer_drugs.
- Linsitinib subject Category:Protein_kinase_inhibitors.
- Linsitinib subject Category:Quinolines.
- Linsitinib type ChemicalCompound.
- Linsitinib type ChemicalSubstance.
- Linsitinib type ChemicalObject.
- Linsitinib type Thing.
- Linsitinib comment "Linsitinib is an experimental drug candidate for the treatment of various types of cancer. It is an inhibitor of the insulin receptor and of the insulin-like growth factor 1 receptor (IGF-1R). This prevents tumor cell proliferation and induces tumor cell apoptosis.Linsitinib was discovered by OSI Pharmaceuticals and is currently in Phase III clinical trials for adrenocortical carcinoma and Phase II clinical trials for lung and ovarian cancers.".
- Linsitinib label "Linsitinib".
- Linsitinib sameAs Linsitinib.
- Linsitinib sameAs m.0n8hqpv.
- Linsitinib sameAs Q6554803.
- Linsitinib sameAs Q6554803.
- Linsitinib wasDerivedFrom Linsitinib?oldid=600987554.
- Linsitinib depiction Linsitinib.svg.
- Linsitinib isPrimaryTopicOf Linsitinib.